Pharmaceutical Technology

DECEMBER 16, 2022

The endometriosis market is expected to grow from $1.05bn in 2020 to $2.72bn in 2030 at a compound annual growth rate (CAGR) of 10.0% The figure below summarises the endometriosis market growth across the 7MM from 2020 to 2030. At the end of 2030, the US will contribute approximately 81.3% of 7MM sales.

Compounding 59

Compounding Labelling 59

STAT

FEBRUARY 3, 2023

The dietary supplement industry has been begging for federal oversight of products containing cannabidiol (CBD), a non-psychoactive compound found in the cannabis plant that is being incorporated into a bewildering range of oils, tinctures, edibles, and other products. But the FDA turned down industry trade groups , and for good reason.

FDA 98

FDA Compounding 98

European Pharmaceutical Review

JULY 24, 2023

A paper published in Pharmaceutics has proposed how a personalised preparation quality assurance programme can achieve this when these products are developed in compounding laboratories. It requests that compounding laboratories adhering to the programme send samples of it. PACMI selects a drug on a quarterly basis.

Compounding 93

Compounding Documentation 93

European Pharmaceutical Review

SEPTEMBER 15, 2023

With a compound annual growth rate (CAGR) of 6.76 percent, the global market of Dercum’s disease treatment in 2030 is predicted to grow to $19.95 Promisingly, Caliway also shared that according to the Global Dercum’s Disease Market Research Report, the global Dercum’s disease treatment market size in 2021 was $11.3

Compounding 119

Compounding 119

European Pharmaceutical Review

FEBRUARY 3, 2023

The facility forms two new fully-automated production lines for liquid and freeze-dried drugs, including highly potent compounds and advanced therapies such as antibody drug conjugates (ADCs). billion by 2030 The post France gets new sterile liquid drug manufacturing facility appeared first on European Pharmaceutical Review.

Dosage 98

Dosage Compounding Pharmaceutical Companies Pharmaceutical Companies 98

European Pharmaceutical Review

FEBRUARY 8, 2023

Yescarta for blood cancer Yescarta is targeting expansions into the first line for diffuse large B-cell lymphoma (DLBCL) and second line for follicular lymphoma in 2030. Breyanzi will exhibit the largest compound annual growth rate (CAGR) at 30 percent, compared to Yescarta’s CAGR of 9 percent. Peak sales are anticipated to reach $1.3

Labelling 98

Labelling Compounding 98

pharmaphorum

AUGUST 2, 2022

The potential for ADCs to combine the best of both mAbs and small molecule drugs means that there has been high interest in developing a successful compound since the first successful clinical trial in 1983. Development of the compound was subsequently ended. Looking to the future. Not all rosy.

Compounding 98

Compounding 98

European Pharmaceutical Review

AUGUST 19, 2022

percent compound annual growth rate (CAGR) of the market include the increasing commercialisation of generics and emerging technologies and small biotechs with limited or no production capabilities driving development in the biopharmaceutical sector. billion by 2026. The market was valued at approximately $100 billion in 2020.

Packaging 98

Packaging Compounding 98

European Pharmaceutical Review

APRIL 3, 2024

Research by Roots Analysis predicts the pharmaceutical contract manufacturing market will value $140 billion by 2030. As such, the sector is expected to grow at a compounded annual growth rate (CAGR) of 6.5 percent between 2022-2030. percent between 2022-2030.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Compounding 52

pharmaphorum

JULY 27, 2022

AmerisourceBergen notes that the US market for DTx is predicted to grow at a compound annual growth rate of nearly 25% between 2022 to 2030, according to figures from Grand View Research which valued the category at $4.2 billion in 2021.

Medical Records 72

Medical Records Compounding 72

European Pharmaceutical Review

DECEMBER 21, 2022

Organic compounds are arguably the foundation of the pharmaceutical industry. All traditional small molecule pharmaceuticals include carbon building blocks” Organic compounds are arguably the foundation of the pharmaceutical industry. In the context of CO 2 neutrality, the years 2030 and 2050 are mentioned as crucial milestones.

Compounding 97

Compounding Pharmaceutical Companies Pharmaceutical Companies Packaging 97

pharmaphorum

MAY 12, 2022

These small drug compounds destabilise proteins by bringing them into proximity with enzymes called E3 ubiquitin ligases that cause them to be broken down. Compounds that modulate the activity of these enzymes have potential in oncology, for example, in blood cancers like multiple myeloma. billion partnership last week. .

Compounding 52

Compounding 52

Roots Analysis

FEBRUARY 27, 2024

How many of the ADCs in development have pyrrolobenzodiazepine (PBD) as warhead: Pyrrolobenzodiazepines are a class of compounds that kill cells by binding their DNA and interfering with replication. They are also more resistant than mAbs to changes in environmental pH and temperature.

Compounding 52

Compounding 52

Roots Analysis

FEBRUARY 28, 2024

The stem cell manufacturing market for CMO is expected to grow at compounded annual growth rate (CAGR) of 18% during the forecast period 2019 – 2030. Specifically, small and mid-sized players in this sector tend to outsource a substantial proportion of clinical and commercial-scale manufacturing processes to contract service providers.

Compounding 40

Compounding Immunization 40

Pharmacy Times

JUNE 19, 2025

With annual growth projected at 36% through 2030 and 10 to 20 new approvals expected each year, oncology pharmacists are likely to encounter these therapies more frequently across care settings. 2-4 In the United States, the FDA had approved 44 cell therapy products as of March 6, 2025.

Compounding 65

Compounding Compounding Pharmacies FDA Immunization 65

European Pharmaceutical Review

NOVEMBER 7, 2024

A report by Azoth Analytics expects that globally, the single-use technology rocking bioreactors market will grow at a compound annual growth rate (CAGR) of 3.9 percent between 2025 and 2030. Key companies profiled in the single-use technology rocking bioreactor market report included Thermo Fisher Scientific Inc.,

Compounding 52

Compounding Vaccines 52

Pharmacy Times

JUNE 18, 2025

The Healthy People 2030 initiative addresses structural health care inequalities and implements programs to ameliorate SDOH. Healthy People 2030. Each unique set of economic, educational, social, and environmental circumstances significantly affects their quality of life and health. REFERENCES 1. Social determinants of health.

Immunization 65

Immunization Compounding Pharmacies Hospitals Chemotherapy 65

ISPE

MARCH 6, 2023

C global warming scenario by 2030, which is widely acknowledged to be necessary to avoid the worst impacts of climate change. This study showed that only 9% of the companies currently have targets aligned with a 1.5°C C global warming scenario.

Packaging 52

Packaging Pharmaceutical Companies Pharmaceutical Companies Compounding 52

Pharmacy Times

JUNE 9, 2025

2019;380:2020-2030. Global Initiative for Asthma. Accessed June 9, 2025. Beasley R, Holliday M, Reddell HK, et al. Controlled trial of budesonide-formoterol as needed for mild asthma. N Engl J Med.

Compounding Pharmacies 73

Compounding Pharmacies Hospitals Immunization Chemotherapy 73

Pharmacy Times

JUNE 12, 2025

The World Health Organization (WHO) has set a global goal to have 90% of girls fully vaccinated with the HPV vaccine by 2030. The vaccine also provides cross-protection against multiple high-risk HPV types beyond those directly targeted.

Vaccines 65

Vaccines Immunization Compounding Pharmacies FDA 65

PharmD Live

MAY 13, 2024

Their projections indicate that approximately 10,000 people will turn 65 each day over the next 19 years, with the population of older adults expected to double to 80 million by 2030. At this rate, nearly half of the older population could be impacted by polypharmacy by 2030. Data from the U.S. in 1994 to 42.4%

Long-Term Care Facilities 105

Long-Term Care Facilities Nursing Homes Prescription Filling Compounding 105

Pharmaceutical Technology

MAY 22, 2023

The possibility of additional funding comes at a time replete with investor uncertainty as a result of ongoing financial instability in the market, which has been compounded by the collapse of Silicon Valley Bank (SVB) and Credit Suisse. billion) by 2030. The UK government also has its own plans for funding research. billion ($18.2

Vaccines 111

Vaccines Compounding Communication 111

PharmTech

JUNE 10, 2025

The global biopharma industry is expected to increase at a compound annual growth rate of 8.97% from 2025 to 2030; this growth is suspected to result from a demand for targeted therapies, new alliances, and increased innovation (1).

Dosage 52

Dosage Vaccines Compounding Immunization 52

Pharmaceutical Technology

MAY 18, 2023

The World Health Organization (WHO) 2021 roadmap outlines plans to eradicate 20 listed diseases, which include leprosy, scabies and mycetoma, by 2030. Neglected tropical diseases are a major global health concern, affecting over 1.7 billion people, many of whom live in the poorest and most vulnerable communities.

Vaccines 52

Vaccines Compounding FDA 52

ISPE

SEPTEMBER 11, 2023

Examples include platforms as small as autonomous units placed within a facility and mobile production trailers for compounding to platforms as large as a prefabricated, self-contained GMP facility. Worldwide Modular Facilities in Pharmaceutical and Biotechnology Industry to 2030 - Impact Analysis of COVID-19.” 6 (2022):215.

Health and Personal Care Stores 52

Health and Personal Care Stores Vaccines Packaging Documentation 52

Pharmacy Times

JUNE 19, 2025

million deaths in 2019, and this is predicted to increase to approximately 23 million annual deaths by 2030. Whole foods contain a mixture of micronutrients, fiber, antioxidants, and other compounds that augment the absorption and application of essential vitamins and minerals.

Compounding Pharmacies 65

Compounding Pharmacies Hospitals Compounding Immunization 65

Drug Topics

JUNE 12, 2025

1 "The label expansion for Mavyret, coupled with the implementation of test and treat models of care, serve as tools to support the public health community in treating more patients and bringing us closer to achieving the global 2030 elimination goal."

FDA 316

FDA Vaccines Labelling Specialty Pharmacies 316

Hospital Pharmacy Europe

JANUARY 19, 2023

Worldwide, more than 700,000 people die by suicide annually and the WHO has set a target to reduce suicides by one third by 2030. The problems for community pharmacists can be compounded by the lack of suitable referral pathways and the fact that patients do not always understand why the pharmacist is asking questions.

Community Pharmacies 98

Community Pharmacies Hospitals Communication Medical Schools 98

PharmTech

JUNE 11, 2025

The financing round was co-led by Kurma Partners , WE Life Sciences , and the French Tech Seed Fund managed by Bpifrance , on behalf of the French government, under the France 2030 initiative. Additional participants included Argobio , Angelini Ventures , CARMA Fund , Capital Grand Est , and Sambrinvest.

Dosage 52

Dosage Packaging Vaccines Compounding 52

PharmaShots

APRIL 3, 2023

The P-III trial (GUARD) results showed no safety signals & were found to be well tolerated with no observed treatment-emergent serious AEs ADX-2191 is a sterile, non-compounded IVT formulation of methotrexate for specific rare retinal diseases. old, for use by women with diabetes who are pregnant & for wear time of up to 15 days.

FDA 40

FDA Compounding Hospitals Vaccines 40

European Pharmaceutical Review

JUNE 27, 2022

The Kigali Summit on Malaria and NTDs , hosted by His Excellency (HE) Paul Kagame, President of the Republic of Rwanda, on Thursday 23 June 2022, gathered world leaders to commit to ending these devastating diseases by the end of 2030. Did you know, 1.7 LXE408 is currently entering Phase II clinical development.

Vaccines 110

Vaccines Communication Documentation Compounding 110

The Checkup by Singlecare

MARCH 10, 2025

Theres a chance that taking these two together can compound their side effects, even causing excessive drowsiness or central nervous system (CNS) depression a medical condition that can lead to confusion, dizziness, impaired coordination, and other symptoms.

Dosage 52

Dosage Labelling FDA Compounding 52

The Checkup by Singlecare

MARCH 14, 2025

Common side effects of liraglutide (as well as brand-name Victoza ) include: Nausea Vomiting Upset stomach Diarrhea or constipation Decreased appetite Compounded GLP-1s vs. generics The reason many people think there is a generic Ozempic (and other similar drugs) is likely due to the constant advertisements for compounded semaglutide.

Compounding 52

Compounding FDA Compounding Pharmacies Dosage 52

Hospital Pharmacy Europe

APRIL 1, 2025

Global health authorities forecast an additional 250,000 annual deaths from climate change between 2030 and 2050. Rising temperatures and extreme weather events are driving higher rates of food- and water-borne illnesses, amongst other conditions. Paradoxically, the healthcare sector itself contributes substantially to GHG emissions.

Intravenous Solutions 52

Intravenous Solutions Hospitals Chemotherapy Compounding 52